Suppr超能文献

[¹²⁵I粒子永久组织间植入治疗非小细胞肺癌单发脑转移瘤的疗效]

[Efficacy of permanent interstitial implantation of 125I seeds for solitary brain metastasis from non-small cell lung carcinoma].

作者信息

Wang Zhong-min, Wu Jing, Wang Guo-chao, Ren Jun-li, Kjelle Drne

机构信息

Department of Radiotherapy, Shanxi Tumor Hospital, Taiyuan, Shanxi 030013, P. R. China.

出版信息

Ai Zheng. 2002 Oct;21(10):1145-8.

Abstract

BACKGROUND & OBJECTIVE: Some studies have already showed that whole brain irradiation (WBI) could cause radiation brain damage. It is necessary to explore a novel treatment modality to replace whole brain irradiation without influencing the therapeutic efficacy. The purpose of this study was to assess the therapeutic efficacy and radiation brain damage of permanent interstitial implantation of 125I seeds following tumor resection for solitary brain metastasis from non-small cell lung carcinoma (NSCLC).

METHODS

Sixty-seven patients with solitary brain metastasis from non-small cell lung carcinoma were randomly assigned into two groups: Thirty-two cases(47.8%) were treated with resection and permanent interstitial implantation of 125I seeds(I), and 35(52.2%) received whole brain irradiation and local-small-field radiation (C). All patients were biopsy-verified non-small cell lung carcinoma, including 42 squamous cell carcinomas and 25 adenocarcinomas. They all were solitary brain metastasis from non-small cell lung carcinoma diagnosed by CT or MRI. After resection of solitary brain metastasis, different numbers of 125I seeds were implanted according to some parameters in group I. In group C, 35 patients received whole brain irradiation to a total dose of 30-39 Gy/3-4 weeks, 2-3 Gy/fraction, 5 fractions/week followed by a boost of 15-25 Gy/2-3 weeks through local-small fields.

RESULTS

The local control rate, the recurrent rate, and the median recurrent time were 96.9%, 15.6%, and 9 months in group I, and 82.9%, 17.1%, and 7 months in group C, respectively. The differences were no significant (P > 0.05). The median survival time, the 1-year survival rate, and the 1-year mortalities were 12 months, 40.6%, and 28.1% in group I, and 9 months, 31.4%, and 37.1% in group C, respectively. The differences were significant(P < 0.05). Acute irradiation response and radiation brain damage were markedly milder in group I than in group C.

CONCLUSIONS

The results from this study show that resection and permanent interstitial implantation of 125I seeds for solitary brain metastasis from non-small cell lung carcinoma can not only improve the survival rates and decrease the mortalities, but also reduce radiation brain damage to improve the life quality. It is a good and effective modality, especially for younger patients. However, further study for long-term effect is needed.

摘要

背景与目的

一些研究已表明全脑照射(WBI)可导致放射性脑损伤。有必要探索一种新的治疗方式来替代全脑照射,同时不影响治疗效果。本研究旨在评估非小细胞肺癌(NSCLC)孤立性脑转移瘤切除术后永久性组织间植入125I粒子的治疗效果及放射性脑损伤情况。

方法

67例非小细胞肺癌孤立性脑转移患者随机分为两组:32例(47.8%)接受肿瘤切除及永久性组织间植入125I粒子治疗(I组),35例(52.2%)接受全脑照射及局部小野照射(C组)。所有患者均经活检证实为非小细胞肺癌,其中鳞癌42例,腺癌25例。均经CT或MRI诊断为非小细胞肺癌孤立性脑转移。I组在孤立性脑转移瘤切除术后,根据一些参数植入不同数量的125I粒子。C组35例患者接受全脑照射,总剂量30 - 39 Gy/3 - 4周,2 - 3 Gy/次,每周5次,随后通过局部小野追加剂量15 - 25 Gy/2 - 3周。

结果

I组局部控制率、复发率及中位复发时间分别为96.9%、15.6%和9个月,C组分别为82.9%、17.1%和7个月。差异无统计学意义(P > 0.05)。I组中位生存时间、1年生存率及1年死亡率分别为12个月、40.6%和28.1%,C组分别为9个月、31.4%和37.1%。差异有统计学意义(P < 0.05)。I组急性照射反应及放射性脑损伤明显轻于C组。

结论

本研究结果表明,非小细胞肺癌孤立性脑转移瘤切除并永久性组织间植入125I粒子不仅可提高生存率、降低死亡率,还可减轻放射性脑损伤、提高生活质量。这是一种良好且有效的治疗方式,尤其适用于年轻患者。然而,尚需进一步研究其长期疗效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验